We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CW icon
1376
Curtiss-Wright
CW
$25.9B
$16K ﹤0.01%
59
+9
+18% +$2.41K
GBX icon
1377
The Greenbrier Companies
GBX
$1.42B
$16K ﹤0.01%
322
+48
+18% +$2.49K
WHR icon
1378
Whirlpool
WHR
$2.76B
$15.9K ﹤0.01%
156
+58
+59% +$5.65K
BILL icon
1379
BILL Holdings
BILL
$4.87B
$15.9K ﹤0.01%
302
+153
+103% +$8.66K
CRNX icon
1380
Crinetics Pharmaceuticals
CRNX
$8.93B
$15.9K ﹤0.01%
354
+77
+28% +$3.56K
NWL icon
1381
Newell Brands
NWL
$2.5B
$15.8K ﹤0.01%
2,469
+1,028
+71% +$7.65K
WERN icon
1382
Werner Enterprises
WERN
$2.23B
$15.8K ﹤0.01%
440
+411
+1,417% +$15K
MAT icon
1383
Mattel
MAT
$4.2B
$15.7K ﹤0.01%
967
+384
+66% +$6.96K
PTVE
1384
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$15.7K ﹤0.01%
1,389
+50
+4% +$665
XPH icon
1385
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
$15.7K ﹤0.01%
395
OTEX icon
1386
Open Text
OTEX
$6.02B
$15.7K ﹤0.01%
523
+180
+52% +$5.77K
PNFP icon
1387
Pinnacle Financial Partners Inc
PNFP
$15.8B
$15.7K ﹤0.01%
196
+42
+27% +$3.35K
ZM icon
1388
Zoom
ZM
$31.4B
$15.7K ﹤0.01%
265
-346
-57% -$21.3K
RH icon
1389
RH
RH
$3.55B
$15.6K ﹤0.01%
64
+62
+3,100% +$16.3K
ESGR
1390
DELISTED
Enstar Group
ESGR
$15.6K ﹤0.01%
51
+18
+55% +$5.4K
STNE icon
1391
StoneCo
STNE
$2.54B
$15.6K ﹤0.01%
1,298
+315
+32% +$4.64K
BBWI icon
1392
Bath & Body Works
BBWI
$3.93B
$15.5K ﹤0.01%
398
+145
+57% +$6.66K
MC icon
1393
Moelis & Co
MC
$4.68B
$15.5K ﹤0.01%
273
FIX icon
1394
Comfort Systems
FIX
$59.6B
$15.5K ﹤0.01%
51
+1
+2% +$318
BHE icon
1395
Benchmark Electronics
BHE
$2.95B
$15.5K ﹤0.01%
393
+16
+4% +$588
FLL icon
1396
Full House Resorts
FLL
$91.6M
$15.5K ﹤0.01%
3,100
ROKU icon
1397
Roku
ROKU
$22.6B
$15.4K ﹤0.01%
257
-11
-4% -$645
MORN icon
1398
Morningstar
MORN
$7.67B
$15.4K ﹤0.01%
52
CSAN icon
1399
Cosan
CSAN
$2.74B
$15.3K ﹤0.01%
1,576
+1,389
+743% +$15.1K
MGPI icon
1400
MGP Ingredients
MGPI
$369M
$15.3K ﹤0.01%
205
+6
+3% +$468

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.